Zobrazeno 1 - 10
of 21
pro vyhledávání: '"Stefanie Hultzsch"'
Autor:
Katarina Dathe, Johanna Frank, Stephanie Padberg, Stefanie Hultzsch, Evelin Beck, Christof Schaefer
Publikováno v:
BMC Pregnancy and Childbirth, Vol 22, Iss 1, Pp 1-11 (2022)
Abstract Background Non-steroidal anti-inflammatory drugs (NSAID) are frequently used to treat pain, fever and inflammatory conditions. Due to evidenced fetotoxicity, treatment with NSAID and metamizole should be avoided in the 3rd trimester of pregn
Externí odkaz:
https://doaj.org/article/f01d578d21444c959ba9c62a4c1d42c8
Publikováno v:
Reproductive Toxicology. 111:129-134
Women and their health care provider (HCP) often seek advice for drug safety in pregnancy at Teratology Information Services (TIS). In turn, TIS ask for details of drug exposure and pregnancy outcome. These data constitute a valuable basis for resear
Externí odkaz:
https://explore.openaire.eu/search/publication?articleId=doi_dedup___::19547e65b62226c8f61a6f1e1e22052f
https://doi.org/10.1016/j.reprotox.2022.05.013
https://doi.org/10.1016/j.reprotox.2022.05.013
Autor:
Christof Schaefer, WE Paulus, Stefanie Hultzsch, Anne-Katrin Fietz, Stephanie Padberg, Katarina Dathe
Publikováno v:
Reproductive toxicology (Elmsford, N.Y.). 103
In contrast to other non-steroidal anti-inflammatory drugs (NSAIDs), naproxen use during pregnancy is not well studied. The objective of this analysis was to assess negative effects on pregnancy outcomes following naproxen exposure in the first trime
Externí odkaz:
https://explore.openaire.eu/search/publication?articleId=doi_dedup___::2341391afc5d64cd117e277c0c13e6ae
https://pubmed.ncbi.nlm.nih.gov/34015472
https://pubmed.ncbi.nlm.nih.gov/34015472
Autor:
Katja Meixner, Katarina Dathe, Anne-Katrin Fietz, Stephanie Padberg, Christof Schaefer, Stefanie Hultzsch, Reinhard Meister, Lucas William Pritchard
Publikováno v:
Reproductive Toxicology. 79:32-38
Ibuprofen is an analgesic frequently used in the 1st and 2nd trimester of pregnancy. Most relevant studies deal with NSAID as a group and do not specifically focus on ibuprofen. In this study, 1117 women exposed to ibuprofen in the 1st trimester were
Externí odkaz:
https://explore.openaire.eu/search/publication?articleId=doi_dedup___::29620f7098d0e70e6f1922a3b7ff768d
https://doi.org/10.1016/j.reprotox.2018.05.003
https://doi.org/10.1016/j.reprotox.2018.05.003
Autor:
Reinhard Meister, Katarina Dathe, Stephanie Padberg, Christof Schaefer, Stefanie Hultzsch, Katja Meixner, Verena Linsenmeier, Tatjana Tissen-Diabaté
Publikováno v:
Reproductive Toxicology. 77:122-129
Diclofenac is a widely used analgesic so that exposure during pregnancy may frequently occur. Most publications have evaluated the safety of NSAIDs on pregnancy outcome as a group of substances. Specific data on diclofenac are rare. This observationa
Externí odkaz:
https://explore.openaire.eu/search/publication?articleId=doi_dedup___::a27f3ad6fcb624597c637ce2ef8b196c
https://doi.org/10.1016/j.reprotox.2018.02.007
https://doi.org/10.1016/j.reprotox.2018.02.007
Autor:
Reinhard Meister, Tatjana Tissen-Diabaté, Anne-Katrin Fietz, Katarina Dathe, Stefanie Hultzsch, Katja Meixner, Stephanie Padberg, Luisa-Maria Köhler, Christof Schaefer
Publikováno v:
European Journal of Clinical Pharmacology. 74:489-495
Cox-2-inhibitors (coxibs) are not recommended in pregnancy but early exposure may occur, for instance in unplanned pregnancies. Experience in pregnancy is limited leading to concerns in patients and their health care providers. Therefore, further dat
Externí odkaz:
https://explore.openaire.eu/search/publication?articleId=doi_dedup___::e1cf56ba2bce84d7a2dca5583012c2ea
https://doi.org/10.1007/s00228-017-2385-1
https://doi.org/10.1007/s00228-017-2385-1
Autor:
Christof Schaefer, Reinhard Meister, Katja Meixner, Stephanie Padberg, Tatjana Tissen-Diabaté, Stefanie Hultzsch, Evelin Beck, Katarina Dathe
Publikováno v:
Pharmacoepidemiology and Drug Safety. 26:1197-1204
Introduction The analgesic metamizole (dipyrone) is not recommended during pregnancy due to limited experience. In several countries, metamizole has no market authorization because of agranulocytosis as a rare but severe adverse effect. However, in o
Externí odkaz:
https://explore.openaire.eu/search/publication?articleId=doi_dedup___::191bdff8e0ad04841360ac4027122be5
https://doi.org/10.1002/pds.4277
https://doi.org/10.1002/pds.4277
Autor:
Reinhard Meister, Katja Meixner, Evelin Beck, Stefanie Hultzsch, Katarina Dathe, Stephanie Padberg, Christof Schaefer, J Frank
Publikováno v:
BJOG : an international journal of obstetrics and gynaecologyReferences. 126(13)
Objective Risk of fetotoxicity after paracetamol exposure in the third trimester. Design Observational cohort study and retrospective case assessment. Setting Germany, 2008-2017. Population Pregnant women exposed to paracetamol. Methods Prospectively
Externí odkaz:
https://explore.openaire.eu/search/publication?articleId=doi_dedup___::40c0621fc6a613e70bd24e610d5a6cd4
https://pubmed.ncbi.nlm.nih.gov/31479565
https://pubmed.ncbi.nlm.nih.gov/31479565
Publikováno v:
European journal of clinical pharmacology. 75(10)
Non-steroidal anti-inflammatory drugs (NSAIDs) are not recommended in the 3rd trimester of pregnancy due to known fetal adverse effects in an advanced gestational age. This investigation was performed to assess whether there is a significant risk of
Externí odkaz:
https://explore.openaire.eu/search/publication?articleId=doi_dedup___::a5751dbcd31bb70fbf277440318c776a
https://pubmed.ncbi.nlm.nih.gov/31273431
https://pubmed.ncbi.nlm.nih.gov/31273431
Autor:
Katarina Dathe, Christof Schaefer, Stefanie Hultzsch, WE Paulus, Anne-Katrin Fietz, Stephanie Padberg
Publikováno v:
Reproductive Toxicology. 97:1
Externí odkaz:
https://explore.openaire.eu/search/publication?articleId=doi_________::1bd5c2485d143235c4259e8ae82ae3d1
https://doi.org/10.1016/j.reprotox.2020.04.004
https://doi.org/10.1016/j.reprotox.2020.04.004